Apolipoprotein D (APOD) antibody

Details for Product No. ABIN111355
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Antigen
Synonyms APOD, apod, zgc:153593, AOPDGN, Apo-D, lipocalin
Reactivity
Human
(42), (23), (18), (12), (12)
Host
Mouse
(34), (7), (4)
Clonality (Clone)
Monoclonal ()
Conjugate
Un-conjugated
(1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1)
Application
Enzyme Immunoassay (EIA), Immunohistochemistry (Frozen Paraffin-embedded Sections) (IHC (frpe)), Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
(32), (19), (16), (10), (6), (4), (3), (1), (1), (1)
Pubmed 7 references available
Quantity 0.2 mL
Shipping to United States (Change)
Availability Will be delivered in 6 to 8 Business Days
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Catalog No. ABIN111355
1,204.50 $
Plus shipping costs $45.00

Order hotline:

  • +1 404 474 4654
  • +1 888 205 9894 (TF)
Immunogen Apo D, a progesterone binding glycoprotein of 24,000 dalton monomer molecular size.
Clone 8CD6
Isotype IgG1
Specificity Reacts with Human Apolipoprotein D.
Purification Ammonium Sulfate Precipitation and dialysis in PBS.
Alternative Name Apolipoprotein D (Apo D)
Background Apo D is localized to steroid-responsive tissues (adrenal cortex, ovary, endometrium, prostate and pituitary). Apocrine epithelium within axillary skin exhibited strongly positive staining for Apo D and peripheral nerves, pituitary and renal tubules were also immunoreactive. Apo D, a Progesterone binding Glycoprotein of 24,000 dalton monomer molecular size, is a constituent of high density lipoprotein in plasma and was first isolated in large quantity as GCDFP-24, the major protein component of most human breast cyst fluids.Synonyms: APOD, Apo-D
Gene ID 347
NCBI Accession NP_001638
UniProt P05090
Research Area Metabolism
Application Notes Suitable for use in ELISA, Western blot and Immunohistochemistry on Paraffin (> 1/200).
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.
Protocol Tissue Sections: Optimal staining: the sections should be pretreated with an antigen unmasking solution. The primary antibody should be incubated 20-60 minutes at room temperature. Dilutions: Primary antibody (concentrated format) may be diluted to > 1: 200 for Biotinbased detection systems.
Restrictions For Research Use only
Format Liquid
Concentration 1.0 mg/mL
Buffer PBS without preservatives.
Preservative Without preservative
Handling Advice Avoid repeated freezing and thawing. This product is photosensitive and should be protected from light
Storage 4 °C/-20 °C
Storage Comment Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
Background publications Kolodny: "Niemann-Pick disease." in: Current opinion in hematology, Vol. 7, Issue 1, pp. 48-52, 2000 (PubMed).

Kalman, McConathy, Araoz et al.: "Apolipoprotein D in the aging brain and in Alzheimer's dementia." in: Neurological research, Vol. 22, Issue 4, pp. 330-6, 2000 (PubMed).

Thomas, Dean, Pavey et al.: "Increased CNS levels of apolipoprotein D in schizophrenic and bipolar subjects: implications for the pathophysiology of psychiatric disorders." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 98, Issue 7, pp. 4066-71, 2001 (PubMed).

General Aspinall, Bentel, Horsfall et al.: "Differential expression of apolipoprotein-D and prostate specific antigen in benign and malignant prostate tissues." in: The Journal of urology, Vol. 154, Issue 2 Pt 1, pp. 622-8, 1995 (PubMed).

Ong, He, Suresh et al.: "Differential expression of apolipoprotein D and apolipoprotein E in the kainic acid-lesioned rat hippocampus." in: Neuroscience, Vol. 79, Issue 2, pp. 359-67, 1997 (PubMed).

Terrisse, Poirier, Bertrand et al.: "Increased levels of apolipoprotein D in cerebrospinal fluid and hippocampus of Alzheimer's patients." in: Journal of neurochemistry, Vol. 71, Issue 4, pp. 1643-50, 1998 (PubMed).

Montpied, de Bock, Lerner-Natoli et al.: "Hippocampal alterations of apolipoprotein E and D mRNA levels in vivo and in vitro following kainate excitotoxicity." in: Epilepsy research, Vol. 35, Issue 2, pp. 135-46, 1999 (PubMed).

Validation Images
Did you look for something else?
back to top